Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes

BMC Dermatology

Volumn 12, Issue , 2012, Pages

  Lesack, Kyle ^a   Naugler, Christopher ^b  

^a O'Brien Centre for the BHSc   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; BIOCHEMISTRY; CELL INFILTRATION; CELL STRUCTURE; COMPUTER ANALYSIS; CONTROLLED STUDY; ELASTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; MORPHOMETRICS; QUANTITATIVE ANALYSIS; STROMA; PATHOLOGY; SKIN TUMOR; STROMA CELL;

CARCINOMA, BASAL CELL; HUMANS; SKIN NEOPLASMS; STROMAL CELLS;

EID: 84857961687     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-12-1     Document Type: Article

References (35)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992, 267:10931-10934.
2. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401. 10.1038/nrc1877, 16572188.
3. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol 2006, 1:119-150. 10.1146/annurev.pathol.1.110304.100224, 18039110.
4. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005, 15:97-101. 10.1016/j.gde.2004.12.003, 2819733, 15661539.
5. Tang Y, Kesavan P, Nakada MT, Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Rev 2004, 2:73-80.
6. Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, Maemondo M, Hong X, Tazawa R, Kikuchi T, Matsushima K, Nukiwa T. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol 2002, 169:469-475.
7. Samoszuk M, Tan J, Chorn G. Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts. Breast Cancer Res 2005, 7:R274-R283. 10.1186/bcr995, 1143574, 15987422.
8. Yashiro M, Ikeda K, Tendo M, Ishikawa T, Hirakawa K. Effect of organ-specific fibroblasts on proliferation and differentiation of breast cancer cells. Breast Cancer Res Treat 2005, 90:307-313. 10.1007/s10549-004-5364-z, 15830145.
9. Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Hyaluronan in human malignancies. Exp Cell Res 2011, 317:383-391. 10.1016/j.yexcr.2010.11.017, 21134368.
10. Kitadai Y. Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron 2010, 3:109-116.
11. Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008, 27:5904-5912. 10.1038/onc.2008.271, 18836471.
12. Mueller MM, Fusenig NE. Friends or foes--bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4:839-849. 10.1038/nrc1477, 15516957.
13. Reuter JA, Ortiz-Urda S, Kretz M, Garcia J, Scholl FA, Pasmooij AM, Cassarino D, Chang HY, Khavari PA. Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. Cancer Cell 2009, 15:477-488. 10.1016/j.ccr.2009.04.002, 3050547, 19477427.
14. Littlepage LE, Egeblad M, Werb Z. Coevolution of cancer and stromal cellular responses. Cancer Cell 2005, 7:499-500. 10.1016/j.ccr.2005.05.019, 15950897.
15. Wadlow RC, Wittner BS, Finley SA, Bergquist H, Upadhyay R, Finn S, Loda M, Mahmood U, Ramaswamy S. Systems-level modeling of cancer-fibroblast interaction. PLoS One 2009, 4:e6888. 10.1371/journal.pone.0006888, 2731225, 19727395.
16. Ichise T, Adachi S, Ohishi M, Ikawa M, Okabe M, Iwamoto R, Mekada E. Humanized gene replacement in mice reveals the contribution of cancer stroma-derived HB-EGF to tumor growth. Cell Struct Funct 2010, 35:3-13. 10.1247/csf.09025, 20190463.
17. Lynch CC, Matrisian LM. Matrix metaloproteinases in tumor-host cell communication. Differentiation 2002, 2:161-174.
18. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337. 10.1038/nature03096, 3050735, 15549095.
19. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
20. MacKie RM. Epidermal skin tumours. Textbook of Dermatology 1992, 2:1488-1495. Oxford: Blackwell Scientific Publications, Champion RH, Burton JL, Ebling FJG, 5.
21. Hales SA, Stamp G, Evans M, Fleming KA. Identification of the origin of cells in human basal cell carcinoma xenografts in mice using in situ hybridization. Br J Dermatol 1989, 120:351-357. 10.1111/j.1365-2133.1989.tb04159.x, 2713256.
22. Carlson JA, Combates NJ, Stenn KS, Prouty SM. Anaplastic neoplasms arising from basal cellcarcinoma xenotransplants into SCID-beige mice. J Cutan Pathol 2002, 29:268-278. 10.1034/j.1600-0560.2002.290502.x, 12100626.
23. Kaur P, Mulvaney M, Carlson JA. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis. Am J Dermatopathol 2006, 28:293-307. 10.1097/00000372-200608000-00002, 16871032.
24. Humphreys TR, Monteiro MR, Murphy GF. Mast cells and dendritic cells in basal cell carcinoma stroma. Dermatol Surg 2000, 26:200-203. 10.1046/j.1524-4725.2000.09207.x, 10759793.
25. Dingemans KP, Ramkema MD, Koopman G, Van Der Wal AC, Das PK, Pals ST. The expression of CD44 glycoprotein adhesion molecules in basal cell carcinomas is related to growth pattern and invasiveness. Br J Dermatol 1999, 140:17-2524. 10.1046/j.1365-2133.1999.02602.x, 10215763.
26. Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989, 11:222. 10.1097/00000372-198906000-00005, 2729527.
27. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982, 49:533-537. 10.1002/1097-0142(19820201)49:3<533::AID-CNCR2820490322>3.0.CO;2-O, 7059912.
28. De Rosa G, Vetrani A, Zeppa P, Zabatta A, Barra E, Gentile R, Fulciniti F, Troncone G, di Benedetto G, Palombini L. Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer 1990, 65:544-549. 10.1002/1097-0142(19900201)65:3<544::AID-CNCR2820650327>3.0.CO;2-O, 2297645.
29. Appel T, Bierhoff E, Appel K, Lindern JV, Bergé S, Niederhagen B. Predictive variables for the biological behaviour of basal cell carcinoma of the face: relevance of morphometry of the nuclei. Br J Oral Maxillofac Surg 2003, 41:147-150. 10.1016/S0266-4356(03)00074-3, 12804537.
30. Swetter SM, Yaghmai D, Egbert BM. Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. J Cutan Pathol 1998, 25:420-425. 10.1111/j.1600-0560.1998.tb01768.x, 9826167.
31. Swetter SM, Boldrick JC, Pierre P, Wong P, Egbert BM. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. J Cutan Pathol 2003, 30:139-146. 10.1034/j.1600-0560.2003.000002.x, 12641794.
32. Ritter N, Cooper J. New resolution independent measures of circularity. J Mathematical Imaging and Vision 2009, 35:117-127.
33. Crowson AN. Basal Cell Carcinoma: Clinical features, Histology, and Biology. Biopsy Interpretation of the Skin 2009, 204-210. Wolters Kluwer: Philadelphia, Crowson AN, Magro CM, Mihm MC.
34. Janisson-Dargaud D, Drurlach A, Lorenzato M, Grange F, Bernard P, Birembaut P. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrances in basal cell carcinoma. J Cutan Pathol 2008, 35:916-921. 10.1111/j.1600-0560.2007.00935.x, 18537864.
35. Papanikolaou S, Bravou V, Gyftopoulos K, Nakas D, Repanti M, Papadaki H. ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion. Histopathology 2010, 56:799-809. 10.1111/j.1365-2559.2010.03556.x, 20546345.